T cell stemness and dysfunction in tumors are triggered by a common mechanism
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Stemness against adversity T lymphocytes are powerful immune cells that can destroy tumors, but cancers have developed tricks to evade killing. Vodnala et al. found that potassium ions in the tumor microenvironment serve a dual role of influencing T cell effector function and stemness (see the Perspective by Baixauli Celda et al. ). Increased potassium impairs T cell metabolism and nutrient uptake, resulting in a starvation state known as autophagy. The increased potassium can also preserve T cells in a stem-like state where they retain the capacity to divide. These seemingly divergent processes are linked to the cellular distribution of acetyl–coenzyme A, which, when manipulated, can restore the ability of human T cells to eliminate tumors in mice. Science , this issue p. eaau0135 ; see also p. 1395
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disabled autophagy due to progressive depletion of spermidine in aging tissues 233 can be expected to interfere with the immune recognition of cancer cells due the incapacity of dendritic cells to recognize autophagy-deficient cancer cells, as well as due to defective T lymphocyte and NK cell responses.163,252”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
Experimental — accuracy not yet measuredIn the citing paper
“This relies on cancer cell-autonomous effects but may also involve the autophagy-driven maintenance of a functional T cell memory stem cell pool, hence avoiding the exhaustion of the anticancer immune response.163”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
In the citing paper
“In addition, the extracellular release of potassium by dying cancer cells leads to the induction of autophagy in CD8+ T cells, thus resulting in the acquisition of a stem cell‐like phenotype and ultimately improving tumor clearance.”
From Autophagy in major human diseases (2021) · cites this paper as Vodnala et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823 · cited 2×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506 · cited 1×
“Nonetheless, the T cells of some patients maintain the capacity to proliferate, persist, and mediate the complete destruction of large tumor deposits (1).”
BackgroundSelf-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140 · cited 1×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 1×
“GSEA revealed that ↑[K]e conditioning resulted in a transcriptional profile that parallels the subset of CD8 T cells recently identified as retaining stemness and the capacity to respond to PD-1 therapy in the setting of chronic antigen exposure (15) (Fig.”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · cited 6×
“We and others have previously identified the transcription factor Tcf7 as being critically involved in the retention of stemcell–like attributes in antigen-experienced T cells (9, 11).”
BackgroundInfluential
Research works printed but not linked: 1
- H. Lodish A. Berk S. Zipursky in Molecular Cell Biology 4th Edition (2000) pp. 1–5.
Cited by
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Raskov, H., Orhan, A., Christensen, J. P., & Gögenur, I. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01048-4 · Cited by 1,687
Blank, C. U., Haining, W. N., Held, W., Hogan, P. G., Kallies, A., Lugli, E., Lynn, R. C., Philip, M., Rao, A., Restifo, N. P., et al. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0221-9 · Cited by 1,603
Self-citationAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Rafiq, S., Hackett, C. S., & Brentjens, R. J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0297-y · Cited by 1,472
“Intriguingly, elevated potassium levels in the TME have been shown to influence nutrient uptake by T cells, resulting in metabolic shifts and epigenetic changes that preserve T cell stemness and inhibit the differentiation of these cells towards effector phenotypes 182 .”
BackgroundGlutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Leone, R. D., Zhao, L., Englert, J. M., Sun, I.-M., Oh, M.-H., Sun, I.-H., Arwood, M. L., Bettencourt, I. A., Patel, C. H., Wen, J., et al. (2019) · Science · doi:10.1126/science.aav2588 · Cited by 1,169
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
CD8+ T cell differentiation and dysfunction in cancer
Philip, M., & Schietinger, A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00574-3 · Cited by 1,052
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Sun, X., Zhang, Y., Li, J., Park, K. S., Han, K., Zhou, X., Xu, Y., Nam, J., Xu, J., Shi, X., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00962-9 · Cited by 788
“…evidence has indicated essential roles of metal ions in immune regulation 23,24 , including T-cell activation (Ca 2+ ) 25,26 and stemness (K + ) 27,28 , activation of inflammasome (K + , Ca 2+ , Na + ) 29–31 , pathogen-host interaction (Fe 2+/3+ , Zn 2+ , Mn 2+ , Cu 2+ ) 32,33 , and cGAS-STING…”
InfluentialMetabolic coordination of T cell quiescence and activation
Chapman, N. M., Boothby, M. R., & Chi, H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0203-y · Cited by 751
Metabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.005 · Cited by 639
Improving cancer immunotherapy through nanotechnology
Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628
CD8+ T cell metabolism in infection and cancer
Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00537-8 · Cited by 612
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Targeting immunogenic cell stress and death for cancer therapy
Galluzzi, L., Guilbaud, E., Schmidt, D., Kroemer, G., & Marincola, F. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00920-9 · Cited by 538
“Such a positive interaction likely involves the favourable effects of autophagy inducers on ATP secretion by stressed cancer cells 36,62 , as well as an improvement in the stem cell-like properties of memory T cells 109 .”
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
Jia, D., Wang, Q., Qi, Y., Jiang, Y., He, J., Lin, Y., Sun, Y., Xu, J., Chen, W., Fan, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.022 · Cited by 479
Precursor exhausted T cells: key to successful immunotherapy?
Kallies, A., Zehn, D., & Utzschneider, D. T. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0223-7 · Cited by 465
Metabolic and epigenetic regulation of T-cell exhaustion
Franco, F., Jaccard, A., Romero, P., Yu, Y.-R., & Ho, P.-C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00280-9 · Cited by 455
Necroptosis and tumor progression
Yan, J., Wan, P., Choksi, S., & Liu, Z.-G. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2021.09.003 · Cited by 445
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Feng, Q., Liu, Z., Yu, X., Huang, T., Chen, J., Wang, J., Wilhelm, J., Li, S., Song, J., Li, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32521-8 · Cited by 419
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 404
T Cell Dysfunction and Exhaustion in Cancer
Zhang, Z., Liu, S., Zhang, B., Qiao, L., Zhang, Y., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00017 · Cited by 385
“Combination treatments aimed at PD1 inhibition and activation of GITR, decrease CD8+ T cell dysfunction and induce a highly proliferative precursor effector memory T cell phenotype (Wang et al., 2018).”
BackgroundCAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Wagner, J., Wickman, E., DeRenzo, C., & Gottschalk, S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.015 · Cited by 380
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 356
“Stemness promotion CAFs with active autophagy release HMGB1 to enhance stemness in tumor cells [306] T cells CD8+ T cell immunity Autophagy in CD8+ T cells promotes or inhibits CD8+ T cell immunity in different tumor [309, 310]”
BackgroundInosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Wang, T., Gnanaprakasam, J. N. R., Chen, X., Kang, S., Xu, X., Sun, H., Liu, L., Rodgers, H., Miller, E., Cassel, T. A., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0219-4 · Cited by 331
Immunometabolic Interplay in the Tumor Microenvironment
Kaymak, I., Williams, K. S., Cantor, J. R., & Jones, R. G. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.09.004 · Cited by 328
“Elevated sodium levels can drive increased inflammatory potential in CD4+ Th17 cells (Kleinewietfeld et al., 2013; Wu et al., 2013), and increased potassium availability can compromise nutrient uptake and effector function in CD8+ T cells (Vodnala et al., 2019).”
BackgroundMetabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Poznanski, S. M., Singh, K., Ritchie, T. M., Aguiar, J. A., Fan, I. Y., Portillo, A. L., Rojas, E. A., Vahedi, F., El-Sayes, A., Xing, S., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.023 · Cited by 306
Li, W., Lu, L., Lu, J., Wang, X., Yang, C., Jin, J., Wu, L., Hong, X., Li, F., Cao, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9013 · Cited by 305
Metabolic adaptation of lymphocytes in immunity and disease
Chapman, N. M., & Chi, H. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.012 · Cited by 305
“Extracellular potassium is elevated in the TME and promotes stem-like programs in T cells, associated with long-term persistence; consequently, potassium-treated T cells have better antitumor immunity (Vodnala et al., 2019).”
BackgroundTwo subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans
Galletti, G., De Simone, G., Mazza, E. M. C., Puccio, S., Mezzanotte, C., Bi, T. M., Davydov, A. N., Metsger, M., Scamardella, E., Alvisi, G., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0791-5 · Cited by 299
Metalloimmunology: The metal ion-controlled immunity
(2020) · Advances in Immunology · doi:10.1016/bs.ai.2019.11.007 · Cited by 292
Photothermal nanofibres enable safe engineering of therapeutic cells
Xiong, R., Hua, D., Van Hoeck, J., Berdecka, D., Léger, L., De Munter, S., Fraire, J. C., Raes, L., Harizaj, A., Sauvage, F., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00976-3 · Cited by 287
Milner, J. J., Toma, C., He, Z., Kurd, N. S., Nguyen, Q. P., McDonald, B., Quezada, L., Widjaja, C. E., Witherden, D. A., Crowl, J. T., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.007 · Cited by 271
“Anti-viral siIEL CD8 T Cells Are Inter- and Intratemporally Heterogeneous It is apparent that Trm cells are transcriptionally distinct from circulating memory populations (Mackay et al., 2013; Milner et al., 2017; Wakim et al., 2012).”
BackgroundPromises and challenges of adoptive T-cell therapies for solid tumours
Morotti, M., Albukhari, A., Alsaadi, A., Artibani, M., Brenton, J. D., Curbishley, S. M., Dong, T., Dustin, M. L., Hu, Z., McGranahan, N., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01353-6 · Cited by 269
“Treating expanding T cells with increased levels of extracellular potassium and acetate resulted in the generation of T cells with retained stemness, evidenced by self-renewal and multipotency.(222) Other strategies have explored the inhibition of T-cell exhaustion by reducing mitochondrial oxidative stress,(223,224)…”
BackgroundFluorescent probes for the detection of disease-associated biomarkers
Dou, W.-T., Han, H.-H., Sedgwick, A. C., Zhu, G.-B., Zang, Y., Yang, X.-R., Yoon, J., James, T. D., Li, J., & He, X.-P. (2022) · Science Bulletin · doi:10.1016/j.scib.2022.01.014 · Cited by 266
Dafni, U., Michielin, O., Lluesma, S. M., Tsourti, Z., Polydoropoulou, V, Karlis, D., Besser, M. J., Haanen, J., Svane, I. M., Ohashi, P. S., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz398 · Cited by 263
Self-citationHochrein, S. M., Wu, H., Eckstein, M., Arrigoni, L., Herman, J. S., Schumacher, F., Gerecke, C., Rosenfeldt, M., Grün, D., Kleuser, B., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.015 · Cited by 246
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Signaling networks in immunometabolism
Saravia, J., Raynor, J. L., Chapman, N. M., Lim, S. A., & Chi, H. (2020) · Cell Research · doi:10.1038/s41422-020-0301-1 · Cited by 248
Cellular networks controlling T cell persistence in adoptive cell therapy
Chan, J. D., Lai, J., Slaney, C. Y., Kallies, A., Beavis, P. A., & Darcy, P. K. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00539-6 · Cited by 243
Developing neoantigen-targeted T cell–based treatments for solid tumors
Yamamoto, T. N., Kishton, R. J., & Restifo, N. P. (2019) · Nature Medicine · doi:10.1038/s41591-019-0596-y · Cited by 238
Self-citationThe yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Schnell, A., Bod, L., Madi, A., & Kuchroo, V. K. (2020) · Cell Research · doi:10.1038/s41422-020-0277-x · Cited by 224
“showed that the TME nutrients and metabolites milieu, especially potassium concentrations, impact the T-cell genome and epigenome, triggering T-cell stemness.(146) Moreover, the exhaustion-fate commitment of CD8 T cells has been recently attributed to the expression of the HMG-box transcription factor TOX, which appea…”
BackgroundFOXO1 is a master regulator of memory programming in CAR T cells
Doan, A. E., Mueller, K. P., Chen, A. Y., Rouin, G. T., Chen, Y., Daniel, B., Lattin, J., Markovska, M., Mozarsky, B., Arias-Umana, J., et al. (2024) · Nature · doi:10.1038/s41586-024-07300-8 · Cited by 223
Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses
Wu, J., Li, G., Li, L., Li, D., Dong, Z., & Jiang, P. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00615-4 · Cited by 219
Memory CD8+ T cell responses to cancer
Han, J., Khatwani, N., Searles, T. G., Turk, M. J., & Angeles, C. V. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101435 · Cited by 216
Stem-like exhausted and memory CD8+ T cells in cancer
Gebhardt, T., Park, S. L., & Parish, I. A. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00615-0 · Cited by 215
“…3 (STAT3) activation) 83 , transforming growth factor-β (TGFβ; via mTOR inhibition) 72,84,85 , IL-33 (by balancing interferon-α (IFNα) and IFNβ signals) 86 , mitochondrial fitness 84,87–89 and extracellular potassium released by dying cancer cells 90 support T PEX cell generation and maintenance.”
BackgroundT cell factor 1: A master regulator of the T cell response in disease
Escobar, G., Mangani, D., & Anderson, A. C. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb9726 · Cited by 211
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells
Baharom, F., Ramirez-Valdez, R. A., Tobin, K. K. S., Yamane, H., Dutertre, C.-A., Khalilnezhad, A., Reynoso, G. V., Coble, V. L., Lynn, G. M., Mulè, M. P., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00810-3 · Cited by 202
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
Huang, H., Long, L., Zhou, P., Chapman, N. M., & Chi, H. (2020) · Immunological Reviews · doi:10.1111/imr.12845 · Cited by 193
Montégut, L., López-Otín, C., & Kroemer, G. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02020-z · Cited by 190
“That, said, mac-roautophagy may also constitute a tumor-suppressive mechanism because it contributes to the maintenance of genomic stability, favors oncogene-induced senescence, mitigates procarcinogenic inflammation, contributes to ferroptotic cell death [62] and favors immunosurveillance [33, 63].”
BackgroundAndrogen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity
Yang, C., Jin, J., Yang, Y., Sun, H., Wu, L., Shen, M., Hong, X., Li, W., Lu, L., Cao, D., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.012 · Cited by 189
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Mo, F., Yu, Z., Li, P., Oh, J., Spolski, R., Zhao, L., Glassman, C. R., Yamamoto, T. N., Chen, Y., Golebiowski, F. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03861-0 · Cited by 183
Self-citationAutophagy as a therapeutic target in pancreatic cancer
Piffoux, M., Eriau, E., & Cassier, P. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01039-5 · Cited by 181
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Zhen, W., Weichselbaum, R. R., & Lin, W. (2023) · Advanced Materials · doi:10.1002/adma.202206370 · Cited by 177
Dietary regulation in health and disease
Wu, Q., Gao, Z.-J., Yu, X., & Wang, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01104-w · Cited by 176
“However, a high K concentration improves the anticancer activity, pluripotency and durability of adoptively transferred CD8 T cells by reprogramming their metabolic processes.(363) Thus, potassium in the TME reshapes T-cell metabolism to enhance anticancer immunological reactions.”
BackgroundInfluentialThe deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity
Song, J., Liu, T., Yin, Y., Zhao, W., Lin, Z., Yin, Y., Lü, D., & You, F. (2021) · EMBO Reports · doi:10.15252/embr.202051162 · Cited by 167
“Uncon-trolled accumulation of extracellular potassium in tumor-surround-ing area leads to T-cell dysfunction (Eil et al , 2016; Vodnala et al , 2019).”
Strategies for the development of metalloimmunotherapies
Sun, X., Zhou, X., Shi, X., Abed, O. A., An, X., Lei, Y. L., & Moon, J. J. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01221-7 · Cited by 163
“Instead, metal-ion-mediated cell reprogramming could serve as metal armours that can increase the persistence of CAR T cell therapy in a simple yet effective manner, as shown by the K + -mediated reprogramming of T cells 10 .”
InfluentialImmunotherapy for Malignant Glioma: Current Status and Future Directions
Wang, H., Xu, T., Huang, Q., Jin, W., & Chen, J. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.12.003 · Cited by 179
Enhanced T cell effector activity by targeting the Mediator kinase module
Freitas, K. A., Belk, J. A., Sotillo, E., Quinn, P. J., Ramello, M. C., Malipatlolla, M. B., Dániel, B., Sándor, K., Klysz, D. D., Bjelajac, J. R., et al. (2022) · Science · doi:10.1126/science.abn5647 · Cited by 166
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Rangel Rivera, G. O., Knochelmann, H. M., Dwyer, C. J., Smith, A. S., Wyatt, M. M., Rivera-Reyes, A. M., Thaxton, J. E., & Paulos, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645242 · Cited by 140
“Citrate is shuttled from the mitochondria where it is converted into acetyl-coA by the action of cytosolic ATP Citrate Lyase (ACL) (50).”
BackgroundExtracellular acidosis restricts one-carbon metabolism and preserves T cell stemness
Cheng, H., Qiu, Y., Xu, Y., Chen, L., Ma, K., Tao, M., Frankiw, L., Yin, H., Xie, E., Pan, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00730-6 · Cited by 163
Methylation across the central dogma in health and diseases: new therapeutic strategies
Liu, R., Zhao, E., Yu, H., Yuan, C., Abbas, M. N., & Cui, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01528-y · Cited by 165
Sodium homeostasis in the tumour microenvironment
Leslie, T. K., James, A. D., Zaccagna, F., Grist, J. T., Deen, S. S., Kennerley, A. J., Riemer, F., Kaggie, J. D., Gallagher, F. A., Gilbert, F. J., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.07.001 · Cited by 159
Miller, K. D., O’Connor, S., Pniewski, K. A., Kannan, T., Acosta, R., Mirji, G., Papp, S. B., Hulse, M., Mukha, D., Hlavaty, S. I., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00636-6 · Cited by 147
“Furthermore, acetate supplementation or enforced expression of ACSS1 enhances the functionality of T cells adoptively transferred into B16 melanoma tumor-bearing mice 55 .”
BackgroundLithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria
Ma, J., Tang, L., Tan, Y., Xiao, J., Wei, K., Zhang, X., Ma, Y., Tong, S., Chen, J., Zhou, N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01738-0 · Cited by 144
“Transition metals, including iron, zinc, manganese, potassium, nickel, copper and cobalt, primarily participate in metabolism and redox regulation 35–38 .”
Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression
Mardiana, S., Solomon, B., Darcy, P. K., & Beavis, P. A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw2293 · Cited by 143
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
Guo, Y., Hu, P., & Shi, J. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c14005 · Cited by 143
Control of immunity via nutritional interventions
Collins, N., & Belkaid, Y. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.004 · Cited by 140
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 155
VISTA: Coming of age as a multi-lineage immune checkpoint
ElTanbouly, M. A., Schaafsma, E., Noelle, R. J., & Lines, J. L. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13415 · Cited by 126
Wei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 148
Salt Sensitivity: Causes, Consequences, and Recent Advances
Bailey, M. A., & Dhaun, N. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.17959 · Cited by 138
“Extracellular potassium impacts other modulators of salt sensitivity, for example, T-cell function, 75 which contributes to the injurious effects of high salt, as discussed below.”
BackgroundDias, J., García, J., Agliardi, G., & Roddie, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101250 · Cited by 137
“67 On the other hand, while IL-2 supplementation has been common practice to support cell expansion, it can drive differentiation into T EM and favor proliferation of T regs , which can hinder therapy ef fi cacy.”
BackgroundTumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Chen, S., Cui, W., Chi, Z., Xiao, Q., Hu, T., Ye, Q., Zhu, K., Yu, W., Wang, Z., Yu, C., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.016 · Cited by 132
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 129
Future Needs in Mast Cell Biology
Varricchi, G., de Paulis, A., Marone, G., & Galli, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184397 · Cited by 131
Improving CAR T-Cell Persistence
Pietrobon, V., Todd, L. A., Goswami, A., Stefanson, O., Yang, Z., & Marincola, F. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910828 · Cited by 132
Zhao, L., Liu, Y., Zhang, S., Wei, L., Cheng, H., Wang, J., & Wang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04821-w · Cited by 124
“These stem cell state T cells are capable of differentiating into tumor killer cells and have achieved excellent tumor control in mice [128].”
BackgroundA unified atlas of CD8 T cell dysfunctional states in cancer and infection
Pritykin, Y., van der Veeken, J., Pine, A. R., Zhong, Y., Şahin, M., Mažutis, L., Pe’er, D., Rudensky, A. Y., & Leslie, C. S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.045 · Cited by 120
Gnanaprakasam, J. R., Kushwaha, B., Liu, L., Chen, X., Kang, S., Wang, T., Cassel, T., Adams, C. M., Higashi, R. M., Scott, D. A., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00856-1 · Cited by 119
First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis
Trzeciak, A., Wang, Y.-T., & Perry, J. S. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.001 · Cited by 99
Coenzyme A fuels T cell anti-tumor immunity
Paul, M. S., Saibil, S. D., Han, S., Israni-Winger, K., Lien, S. C., Laister, R. C., Sayad, A., Penny, S. L., Amaria, R. N., Haydu, L. E., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.010 · Cited by 118
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Pansy, K., Uhl, B., Krstić, J., Szmyra, M., Fechter, K., Santiso, A., Thüminger, L., Greinix, H., Kargl, J., Prochazka, K. T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413311 · Cited by 124
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Rangan, P., & Mondino, A. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004147 · Cited by 104
Metabolic waypoints during T cell differentiation
Wilfahrt, D. N., & Delgoffe, G. M. (2024) · Nature Immunology · doi:10.1038/s41590-023-01733-5 · Cited by 119
“Elevated levels of potassium in tumor microenvironments also deplete acetyl-CoA, thus limiting acetylation of genes encoding T cell effector molecules 129 .”
Metal‐based smart nanosystems in cancer immunotherapy
Luo, Y., He, X., Du, Q., Xu, L., Xu, J., Wang, J., Zhang, W., Zhong, Y., Guo, D., Liu, Y., et al. (2024) · Exploration · doi:10.1002/exp.20230134 · Cited by 112
Metabolic Regulation of Cell Fate and Function
Ghosh-Choudhary, S. K., Liu, J., & Finkel, T. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.12.005 · Cited by 115
Self-citationLiu, S., Zhang, Y., Liu, Y., Wang, W., Gao, S., Yuan, W., Sun, Z., Liu, L., & Wang, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02076-y · Cited by 110
“There are many factors that impede CD8 T-cell infiltration and activation during tumour progression, such as reduced tumour perfusion [45], blocked antigen presentation [40], high-potassium environment [46] and high expression of inhibitory receptors [47].”
BackgroundRegulators of CD8+ T cell exhaustion
Sun, Q., & Dong, C. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01221-x · Cited by 114
“Prolonged in vitro exposure to elevated extracellular potassium limits CD8 + T cell terminal differentiation and promotes superior in vivo persistence and durable antitumour responses upon adoptive transfer 186 .”
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Liu, S., Sun, Q., & Ren, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01430-8 · Cited by 114
“This is achieved by limiting nutrient uptake by T cells, triggering autophagy, and reducing histone acetylation at exhaustion loci [144].”
BackgroundNair, R., Somasundaram, V., Kuriakose, A., Krishn, S. R., Raben, D., Salazar, R. L., & Nair, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548234 · Cited by 111
Nutrients: Signal 4 in T cell immunity
Raynor, J. L., & Chi, H. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20221839 · Cited by 108
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
Qiu, Y., Su, Y., Xie, E., Cheng, H., Du, J., Xu, Y., Pan, X., Wang, Z., Chen, D. G., Hong, Z., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.11.003 · Cited by 109
Adoptive Immunotherapy beyond CAR T-Cells
Titov, A., Zmievskaya, E., Ganeeva, I., Valiullina, A., Petukhov, A., Rakhmatullina, A., Рифкатовна, М. Р., Fainshtein, M., Rizvanov, A. A., & Bulatov, E. (2021) · Cancers · doi:10.3390/cancers13040743 · Cited by 110
“Moreover, the elevation of potassium levels in the medium during TIL expansion led to the less differentiated T-cells that showed long-term persistence within tumors resulting in prolonged survival and better tumor regression in melanoma mouse model [52].”
Background
Metadata
- Authors
- Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., Palmer, D. C., Kruhlak, M. J., Liu, X., Locasale, J. W., Huang, J., Roychoudhuri, R., Finkel, T., Klebanoff, C. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Duke University (US)
- Babraham Institute (GB)
- University of Pittsburgh (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Vodnala, Suman Kumar
- Eil, Robert
- Restifo, Nicholas P.
- ORCID
- Vodnala, Suman Kumar
- Eil, Robert
- Kishton, Rigel J.
- Sukumar, Madhusudhanan
- Yamamoto, Tori N.
- Ha, Ngoc-Han
- Lee, Ping-Hsien
- Shin, MinHwa
- Patel, Shashank J.
- Yu, Zhiya
- Palmer, Douglas C.
- Kruhlak, Michael J.
- Liu, Xiaojing
- Locasale, Jason W.
- Huang, Jing
- Roychoudhuri, Rahul
- Finkel, Toren
- Klebanoff, Christopher A.
- Restifo, Nicholas P.
- Venue
- Science
- Published
- 2019-03-29
- Volume
- 363
- Issue
- 6434
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8194369
- OpenAlex
- W2924300946
- Cited by
- 552
- References
- 49
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 78 · 2023: 70 · 2022: 86 · 2021: 76 · 2020: 73 · 2019: 36
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (129832-RSG-16-214-01-TBE)
- National Cancer Institute (P30 CA008748)
- NIH Clinical Center
- Damon Runyon Cancer Research Foundation
- Parker Institute for Cancer Immunotherapy
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell stemness, T cell dysfunction, tumor microenvironment, potassium ions, T cell metabolism, nutrient uptake, autophagy, acetyl-CoA, T cell exhaustion, antitumor immunity, tumor immune evasion
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Autophagy, Cell Differentiation, Histones, Humans, Immune Tolerance, Lymphocyte Activation, Mice, Inbred C57BL, Neoplasms, Potassium, Stem Cells, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Caloric Restriction, Epigenesis, Genetic, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.